Improvements in post-stroke pain, brain fog, dexterity, vision, and spasticity after PSE treatment by Dr. Tobinick, 2 years after stroke. Filmed on September 16, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Immediate improvement in balance, walking, vision, spasticity, and brain fog after PSE treatment performed by Danielle Ucci, PA-C, 9 months after stroke. Filmed on September 5, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improved quality of life, spasticity, fatigue, and hand function after perispinal etanercept treatment by Edward Tobinick, M.D., 4 years after stroke. Filmed on August 12, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Immediate improvement in left-sided neglect, speech, sensation, and left arm flexion after PSE treatment by Dr. Tobinick, 4 years after hemorrhagic stroke. Filmed on July 24, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0
Improvements in walking, vision, spasticity, speech, sensation, and taste after PSE treatment by Dr. Tobinick, 6.5 years after stroke. Filmed on July 10 & July 15, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Comments: 0